CYTORI THERAPEUTICS INC Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that the company has been selected to present at the Biotech Showcase™ at 3:30 PM Pacific Time (6:30 PM Eastern Time) on Monday, January 12, 2015. The presentation will take place in the C-Mission II room at the Parc 55 Wyndham Hotel in San Francisco.
Marc Hedrick, CEO and President of Cytori Therapeutics, will provide an update on current corporate activities and recent developments, including its recently announced STAR trial.
On December 10, 2014, Cytori announced its plan to begin a US pivotal trial, the STAR trial, designed to evaluate the efficacy of Cytori Cell Therapy™ in treating impairment in hand function due to scleroderma. Further details regarding the therapy and planned trial will be presented at the conference.
A live audio webcast of the presentation will be available under the investor relations section of Cytori’s website at www.cytori.com. A replay of the presentation will be available for 30 days following the event. Please connect to Cytori’s website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.
About Biotech Showcase
The Biotech Showcase 2015 Conference (www.ebdgroup.com/bts) is one of the most significant healthcare investor conferences of the year. It is designed to provide private and public biotechnology and life sciences companies the opportunity to present to, and meet with, public and private investors, and pharmaceutical executives. This is the 7th year for the Biotech Showcase. More than 1700 investors and biopharmaceutical executives from around the world are expected to attend.
About Cytori Therapeutics, Inc.
Cytori Therapeutics is a late stage cell therapy company developing autologous cell therapies from adipose tissue to treat a variety of medical conditions. Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy™ acts principally by improving blood flow, modulating the immune system, and facilitating wound repair. As a result, Cytori Cell Therapy™ may provide benefits across multiple disease states and can be made available to the physician and patient at the point-of-care through Cytori’s proprietary technologies and products. For more information: visit www.cytori.com or follow Cytori on Twitter www.twitter.com/cytori.
